» Articles » PMID: 33151893

Effective Control of COVID-19 in South Korea: Cross-Sectional Study of Epidemiological Data

Abstract

Background: South Korea is one of the few countries that has succeeded in flattening the curve of new COVID-19 cases and avoiding a second outbreak by implementing multiple strategies, ranging from an individual level to the population level.

Objective: We aim to discuss the unique strategies and epidemiological characteristics of COVID-19 in South Korea and present a summary of policies implemented by the Korean government during the COVID-19 pandemic.

Methods: We designed a cross-sectional study of epidemiological data published by the Korea Centers for Disease Control and Prevention on October 1, 2020. We analyzed detailed epidemiological information of COVID-19 cases, including the number of confirmed cases and resulting deaths.

Results: As of October 1, 2020, a total of 23,889 confirmed COVID-19 cases and 415 deaths were reported in South Korea. In this paper, we present data on the epidemiological characteristics and transmission of the disease and discuss how the South Korean government, health care providers, and society responded to the COVID-19 outbreak.

Conclusions: Understanding the epidemiological characteristics of COVID-19 in South Korea and the government's successful efforts in managing the spread of the disease can provide important insights to other countries dealing with the ongoing pandemic.

Citing Articles

COVID-19 infection and severe clinical outcomes in patients with kidney disease by vaccination status: a nationwide cohort study in Korea.

Woo J, Choi A, Jung J, Shin J Epidemiol Health. 2024; 46:e2024065.

PMID: 39054627 PMC: 11576527. DOI: 10.4178/epih.e2024065.


Influencing Factors of Delayed Diagnosis of COVID-19 in Gangwon, South Korea.

Park M, Jeong S, Park Y, Kim S, Kim Y, Kim E Int J Environ Res Public Health. 2024; 21(5).

PMID: 38791855 PMC: 11121085. DOI: 10.3390/ijerph21050641.


Changing Trends in the Incidence and Clinical Features of Pneumonia in Non-HIV Patients before and during the COVID-19 Era and Risk Factors for Mortality between 2016 and 2022.

Kang J Life (Basel). 2023; 13(6).

PMID: 37374118 PMC: 10304474. DOI: 10.3390/life13061335.


Review of science and technology innovation policies in major innovative-oriented countries in response to the COVID-19 pandemic.

Yun T Biosaf Health. 2023; 5(1):8-13.

PMID: 36588927 PMC: 9793148. DOI: 10.1016/j.bsheal.2022.12.001.


The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea.

Kim S, Jhun B, Jeong B, Park H, Kim H, Kwon O J Korean Med Sci. 2022; 37(32):e250.

PMID: 35971764 PMC: 9424694. DOI: 10.3346/jkms.2022.37.e250.


References
1.
Seong S, Kim Y, Khang Y, Park J, Kang H, Lee H . Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016; 46(3):799-800. PMC: 5837262. DOI: 10.1093/ije/dyw253. View

2.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

3.
Kim J, Choe P, Oh Y, Oh K, Kim J, Park S . The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: Implication for Infection Prevention and Control Measures. J Korean Med Sci. 2020; 35(5):e61. PMC: 7008073. DOI: 10.3346/jkms.2020.35.e61. View

4.
Tang B, Xia F, Tang S, Bragazzi N, Li Q, Sun X . The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China. Int J Infect Dis. 2020; 95:288-293. PMC: 7162790. DOI: 10.1016/j.ijid.2020.03.018. View

5.
Bedford J, Enria D, Giesecke J, Heymann D, Ihekweazu C, Kobinger G . COVID-19: towards controlling of a pandemic. Lancet. 2020; 395(10229):1015-1018. PMC: 7270596. DOI: 10.1016/S0140-6736(20)30673-5. View